Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |
Los Angeles, CA: A $325 million preliminary settlement has been reached by Pfizer Inc and Warner-Lambert Co. LLC and plaintiffs who filed a consumer fraud class action lawsuit over the marketing The gabapentin class action lawsuit was filed in 2022 against three pharmaceutical companies – Teva, Pfizer, and Greenstone – accusing them of misrepresenting the drug’s risks and overstating its benefits. Neurontin is an anticonvulsant drug used to treat partial seizures and nervous system pain. Some serious side effects have been reported. These include respiratory disease, allergic reactions, and suicidal thoughts. There were lawsuits filed against the drug companies behind Neurontin for trying to get doctors to prescribe the medication for unapproved uses. Health care and insurance providers Gabapentin, an anti-seizure drug marketed by Pfizer Laboratories in the United States under the trademark name Neurontin, has been the subject of numerous claims of malfeasance in gabapentin side effects lawsuits, with the Pfizer company intentionally and knowingly marketing the medication for uses not approved by the FDA (Food and Drug Legal Urge offers daily legal insights, news, and analysis to simplify complex laws. Explore expert content that informs, empowers, and sparks legal curiosity. Is Gabapentin the Newest Prescription Drug Killer? Gabapentin’s potential for abuse, especially in combination with opioids, may have been misjudged — but the drug remains safe for approved uses. Neurontin (generic name: gabapentin) was FDA-approved in 1993 for use as an anticonvulsant for people suffering from partial seizures associated with epilepsy. It is also FDA-approved for the Pfizer, the world's largest drug maker, pleaded guilty on 13 May to numerous civil and criminal charges for illegally promoting the off-label use of gabapentin (Neurontin). It has agreed to pay a $240m (£136m; €200m) criminal fine and $152m to state and federal healthcare programmes. The fine is the second largest given in the industry. Meanwhile, off-label sales of gabapentin continue to Gabapentin (available under the brand names Neurontin and Gralise and multiple generic versions) was first approved by the FDA in the U.S. in 1993 as an add-on therapy to treat certain types of seizures and more recently to treat neuropathic pain due to shingles infection (a condition known as postherpetic neuralgia). American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. (hereinafter together “Pfizer”) have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products. Gabapentin lawsuits arise from claims of serious side effects and insufficient warnings about risks associated with the medication. Neurontin Lawsuit | 2025 Latest Updates The prescription pain reliever Neurontin (generic gabapentin) has recently been linked to an increased risk for Stevens-Johnson syndrome (SJS), a severe skin disorder in which the top layer of the skin dies, followed by a painful rash that spreads and blisters. Explore the potential for seeking compensation in gabapentin-related memory loss cases, including legal grounds, evidence, and filing deadlines. Gabapentin, commonly sold under the brand name Neurontin, is a prescription drug used to treat seizures, restless leg syndrome, and pain caused by shingles. While it has been effective for some patients, there have been several cases of adverse effects and potential health concerns associated with its use. Kopchinski says he was inspired by David Franklin, who filed a whistle-blower lawsuit against Pfizer for promoting Neurontin — at the time approved only to control seizures — for unapproved Redirecting to In addition to being used to treat pain, gabapentin is used off label to treat anxiety, alcohol use disorder (AUD), alcohol withdrawal, depression, substance use disorders (SUDs), sleep problems, and more. However, the data to support these off-label uses of gabapentin are mixed, especially for long-term use. The manufacturers of the drug Neurontin reached a $325 million class action lawsuit settlement Wednesday over allegations they fraudulently marketed the prescription drug, which is used to treat seizures, restless leg syndrome, and pain caused by shingles. If approved, third-party payers of the drug will be eligible to claim a cash award from the Neurontin class action settlement, announced The FDA has warned that gabapentin and pregabalin, used to treat a range of conditions including pain and seizures, may cause serious breathing problems.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
|